Search research articles
Contact Us
Filters
Showing results (611-620 of 706) with videos related to
Page
of 71
Sort By:
Journal of Neuro-Oncology
|
April 14, 2017
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach
Taryn B Fay-McClymont, Danielle M Ploetz, Don Mabbott, et al.
Acta Neuropathologica
|
February 11, 2012
A prognostic gene expression signature in infratentorial ependymoma
Khalida Wani, Terri S Armstrong, Elizabeth Vera-Bolanos, et al.
Neuro-Oncology
|
December 26, 2023
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, et al.
Journal of Medicinal Chemistry
|
June 14, 2012
Discovery of a potent, selective, and orally bioavailable acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017)
James S Scott, Suzanne S Bowker, Joanne Deschoolmeester, et al.
Journal of Neuro-Oncology
|
May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104
Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Neuro-Oncology
|
January 1, 2017
Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study
Allison A King, Kristy Seidel, Chongzhi Di, et al.
Pediatric Blood & Cancer
|
April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 8, 2021
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase
Daniel H O' Donovan, Clare Gregson, Martin J Packer, et al.
Journal of Medicinal Chemistry
|
July 11, 2024
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer
Sharan K Bagal, Peter C Astles, Coura Diène, et al.
Acta Neuropathologica
|
August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation
Cheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Page
of 71
Search research articles
Search
Showing results (611-620 of 706) with videos related to
Sort By:
Page
of 71
Journal of Neuro-Oncology
|
April 14, 2017
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach
Taryn B Fay-McClymont, Danielle M Ploetz, Don Mabbott, et al.
Acta Neuropathologica
|
February 11, 2012
A prognostic gene expression signature in infratentorial ependymoma
Khalida Wani, Terri S Armstrong, Elizabeth Vera-Bolanos, et al.
Neuro-Oncology
|
December 26, 2023
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, et al.
Journal of Medicinal Chemistry
|
June 14, 2012
Discovery of a potent, selective, and orally bioavailable acidic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid (AZD4017)
James S Scott, Suzanne S Bowker, Joanne Deschoolmeester, et al.
Journal of Neuro-Oncology
|
May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104
Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Neuro-Oncology
|
January 1, 2017
Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study
Allison A King, Kristy Seidel, Chongzhi Di, et al.
Pediatric Blood & Cancer
|
April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 8, 2021
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase
Daniel H O' Donovan, Clare Gregson, Martin J Packer, et al.
Journal of Medicinal Chemistry
|
July 11, 2024
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer
Sharan K Bagal, Peter C Astles, Coura Diène, et al.
Acta Neuropathologica
|
August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation
Cheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Page
of 71